FDA told advisers drug to be rejected

Posted: December 27, 2012 at 12:56 a.m.

Three members of an independent advisory panel say they received as much as a day’s notice in May 2010 before U.S. regulators rejected a drug from Inter-Mune Inc., now tied to an insider-trading probe of SAC Capital Advisors LP.

This story is only available from our archives.

Business, Pages 19 on 12/27/2012


« Previous Story

Sales less merry, bright than retailers had h...

In this Wednesday, Dec. 19, 2012, photo, a customer shops for greeting cards at a Target store in Chicago. U.S. holiday retail sales this year are the weakest since 2008, after a shopping season disrupted by storms and rising uncertainty among consumers. A report out Tuesday, Dec. 25, 2012, that tracks spending, called MasterCard Advisors SpendingPulse, says holiday sales increased 0.7 percent. Analysts had expected sales to grow 3 to 4 percent. (AP Photo/Nam Y. Huh)

Shoppers spent cautiously this Christmas, a disappointment for retailers who slashed prices to lure people int... Read »

Next Story »

Stocks slide on slow Christmas sales

U.S. stocks fell Wednesday for the third trading day in a row. Disappointing holiday sales weighed heavily on retail companies, and the unwelcome “fiscal cliff” package of ... Read »